Skip to content

Allphase Pharma Consulting, LLC

A Professional Service Provider for the Pharma Industry

Allphase Pharma Consulting, LLC
Menu

Primary menu

  • CONTACT
  • BLOGS
    • The Viewpoint
    • The News
    • Recent Literature
    • Did you know…?
    • QIDP Antibiotics
  • LEGAL
  • WELCOME

Secondary menu

  • The News
  • The Viewpoint
  • Did you know…?
  • Recent Literature
  • QIDP Antibiotics

Tag Archives: duration response relationship

Efficacy and Treatment Duration: Where is the Tipping Point?

Posted on March 14, 2017 by Harald — No Comments ↓

Development pf antibacterials differs in several important ways from drug development in other areas, and the lack of standard dose-finding is just one of them. Dose-finding in its most basic form involves ascending amounts of drug for efficacy and safety; for antibiotics, however, an effective dose can be predicted nowadays Continue reading Efficacy and Treatment Duration: Where is the Tipping Point?→

Share this:

  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to print (Opens in new window) Print
  • Click to email a link to a friend (Opens in new window) Email
  • Click to share on WhatsApp (Opens in new window) WhatsApp

Like this:

Like Loading...
Posted in Recent Literature, The Viewpoint | Tagged acute otitis media, Allphase Pharma Consulting, amoxicillin-clavulanate, amoxiclav, antibiotic blog, AOM, Avelox, cefaclor, Cefditoren, cIAI, Cipro, ciprofloxacin, complicated intra-abdominal infection, cystitis, duration response relationship, efficacy - duration of therapy relationship, Harald Reinhart, moxifloxacin, PCT, penicillin, pharyngitis, PK/PD, procalcitonin test, Tipping Point for efficacy, TMP/SMX, tonsillitis, uncomplicated UTI, uUTI, VAP, ventilator-associated pneumonia | Leave a reply

Go back

Your message has been sent

Rating(required)
Warning

Footer Menu

Footer menu

  • CONTACT
  • BLOGS
  • LEGAL
  • WELCOME
  • Email
Copyright © 2026 Allphase Pharma Consulting, LLC. All Rights Reserved.
Theme: Catch Box by Catch Themes
Scroll Up
%d